{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T17:55:40Z","timestamp":1777658140573,"version":"3.51.4"},"reference-count":28,"publisher":"Baskent University","issue":"Suppl 5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.6002\/ect.pedsymp2024.o15","type":"journal-issue","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T05:12:01Z","timestamp":1730351521000},"source":"Crossref","is-referenced-by-count":1,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Horslen S, Barr ML, Christensen LL, Ettenger R, Magee JC. Pediatric transplantation in the United States, 1996-2005. Am J Transplant. 2007;7(5 Pt 2):1339-1358. doi:10.1111\/j.1600-6143.2007.01780.x","DOI":"10.1111\/j.1600-6143.2007.01780.x"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Vanichanan J, Udomkarnjananun S, Avihingsanon Y, Jutivorakool K. Common viral infections in kidney transplant recipients. Kidney Res Clin Pract. 2018;37(4):323-337. doi:10.23876\/j.krcp.18.0063","DOI":"10.23876\/j.krcp.18.0063"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Helantera I, Egli A, Koskinen P, Lautenschlager I, Hirsch HH. Viral impact on long-term kidney graft function. Infect Dis Clin North Am. 2010;24(2):339-371. doi:10.1016\/j.idc.2010.02.003","DOI":"10.1016\/j.idc.2010.02.003"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20(3):629-637. doi:10.1681\/ASN.2008030287","DOI":"10.1681\/ASN.2008030287"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Dharnidharka VR, Caillard S, Agodoa LY, Abbott KC. Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation. 2006;81(12):1662-1667. doi:10.1097\/01.tp.0000226068.66819.37","DOI":"10.1097\/01.tp.0000226068.66819.37"},{"key":"ref5","unstructured":"6. Saad EJ, Fernandez P, Cardozo Azua AE, et al. Infections in the first year after renal transplant. Medicina (B Aires). 2020;80(6):611-621."},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Kidney Disease: Improving Global Outcomes Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant. 2009;9 Suppl 3:S1-155. doi:10.1111\/j.1600-6143.2009.02834.x","DOI":"10.1111\/j.1600-6143.2009.02834.x"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Aloufi M, Alzahrany G, Abdulmajeed N, et al. Viral infections after kidney transplantation in a cohort of children: a retrospective single-center study. Transplant Proc. 2019;51(2):522-525. doi:10.1016\/j.transproceed.2019.01.010","DOI":"10.1016\/j.transproceed.2019.01.010"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Babel N, Fendt J, Karaivanov S, et al. Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples. Transplantation. 2009;88(1):89-95. doi:10.1097\/TP.0b013e3181aa8f62","DOI":"10.1097\/TP.0b013e3181aa8f62"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Bal Z, Uyar ME, Tutal E, et al. Cytomegalovirus infection in renal transplant recipients: one center's experience. Transplant Proc. 2013;45(10):3520-3523. doi:10.1016\/j.transproceed.2013.08.098","DOI":"10.1016\/j.transproceed.2013.08.098"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Hwang EA, Kang MJ, Han SY, Park SB, Kim HC. Viral infection following kidney transplantation: long-term follow-up in a single center. Transplant Proc. 2004;36(7):2118-2119. doi:10.1016\/j.transproceed.2004.08.008","DOI":"10.1016\/j.transproceed.2004.08.008"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Keskinoglu A, Bulut IK, Taner S, Turkes AZ, Kabasakal C. Cytomegalovirus experience in pediatric kidney transplantation in 26 years' time. Transplant Proc. 2020;52(10):3186-3191. doi:10.1016\/j.transproceed.2020.03.023","DOI":"10.1016\/j.transproceed.2020.03.023"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Sagedal S, Nordal KP, Hartmann A, et al. A prospective study of the natural course of cytomegalovirus infection and disease in renal allograft recipients. Transplantation. 2000;70(8):1166-1174. doi:10.1097\/00007890-200010270-00007","DOI":"10.1097\/00007890-200010270-00007"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Abad CL, Razonable RR. Alpha-herpes virus infections among renal transplant recipients. Semin Nephrol. 2016;36(5):344-350. doi:10.1016\/j.semnephrol.2016.05.011","DOI":"10.1016\/j.semnephrol.2016.05.011"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Kirnap M, Akdur A, Ayvazoglu Soy HE, et al. Prevalence and outcome of herpes zoster infection in renal transplant recipients. Exp Clin Transplant. 2015;13 Suppl 1:280-283. doi:10.6002\/ect.mesot2014.p113","DOI":"10.6002\/ect.mesot2014.P113"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant. 2004;4(1):108-115. doi:10.1046\/j.1600-6143.2003.00287.x","DOI":"10.1046\/j.1600-6143.2003.00287.x"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol. 2007;2 Suppl 1:S47-56. doi:10.2215\/CJN.01060307","DOI":"10.2215\/CJN.01060307"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Liefeldt L, Buhl M, Schweickert B, et al. Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy. Nephrol Dial Transplant. 2002;17(10):1840-1842. doi:10.1093\/ndt\/17.10.1840","DOI":"10.1093\/ndt\/17.10.1840"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Malbora B, Saritas S, Ataseven E, et al. Pure red cell aplasia due to parvovirus B19: erythropoietin-resistant anemia in a pediatric kidney recipient. Exp Clin Transplant. 2017;15(3):369-371. doi:10.6002\/ect.2016.0263","DOI":"10.6002\/ect.2016.0263"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Hai An HP, Diem HT, Cuong NT. Parvovirus B19-associated anemia in kidney transplant recipients: a single-center experience. Transplant Proc. 2019;51(8):2693-2696. doi:10.1016\/j.transproceed.2019.03.076","DOI":"10.1016\/j.transproceed.2019.03.076"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Guo YM, Ishii K, Hirokawa M, et al. CpG-ODN 2006 and human parvovirus B19 genome consensus sequences selectively inhibit growth and development of erythroid progenitor cells. Blood. 2010;115(22):4569-4579. doi:10.1182\/blood-2009-08-239202","DOI":"10.1182\/blood-2009-08-239202"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Eid AJ, Ardura MI; American Society of Transplantation Infectious Diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019;33(9):e13535. doi:10.1111\/ctr.13535","DOI":"10.1111\/ctr.13535"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6). doi:10.1542\/peds.2020-0702","DOI":"10.1542\/peds.2020-0702"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Haberal M. COVID-19 update. Exp Clin Transplant. 2020;18(2):139-140. doi:10.6002\/ect.2020.000e","DOI":"10.6002\/ect.2020.000e"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Akalin E, Azzi Y, Bartash R, et al. COVID-19 and kidney transplantation. N Engl J Med. 2020;382(25):2475-2477. doi:10.1056\/NEJMc2011117","DOI":"10.1056\/NEJMc2011117"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Alberici F, Delbarba E, Manenti C, et al. Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy. Kidney Int Rep. 2020;5(5):580-585. doi:10.1016\/j.ekir.2020.04.001","DOI":"10.1016\/j.ekir.2020.04.001"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Stern M, Hirsch H, Cusini A, et al. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. Transplantation. 2014;98(9):1013-1018. doi:10.1097\/TP.0000000000000160","DOI":"10.1097\/TP.0000000000000160"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28. Tong CY, Bakran A, Peiris JS, Muir P, Herrington CS. The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation. 2002;74(4):576-578. doi:10.1097\/00007890-200208270-00026","DOI":"10.1097\/00007890-200208270-00026"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T02:52:39Z","timestamp":1730429559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2024\/22\/10\/5\/60\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":28,"journal-issue":{"issue":"Suppl 5","published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.pedsymp2024.o15","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}